...
首页> 外文期刊>Case Reports in Ophthalmological Medicine >Pneumatic Displacement with Perfluoropropane Gas and Intravitreal Tissue Plasminogen Activator for Subretinal Subfoveal Hemorrhage after Focal Laser Photocoagulation in Central Serous Chorioretinopathy
【24h】

Pneumatic Displacement with Perfluoropropane Gas and Intravitreal Tissue Plasminogen Activator for Subretinal Subfoveal Hemorrhage after Focal Laser Photocoagulation in Central Serous Chorioretinopathy

机译:中心性浆液性脉络膜视网膜病变局灶性激光光凝后全氟丙烷气和玻璃体内组织纤溶酶原激活剂治疗视网膜下凹下大出血

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective. To report the visual and anatomic outcomes of pneumatic displacement with perfluoropropane (C3F8) gas and intravitreal tissue plasminogen activator (IVTPA) for subretinal subfoveal hemorrhage after focal laser photocoagulation in central serous chorioretinopathy (CSCR).Method. Interventional, retrospective case report of one eye (one patient). Outcome measures included visual acuity (VA), central macular thickness (CMT), and size of the lesion at two weeks of followup. Fluorescein angiography (FA) and optical coherent tomography (OCT) were used to measure anatomic outcomes.Results. A 35-year-old man with history of chronic CSCR received focal laser photocoagulation in the right eye two days before presentation. At initial examination, VA was 20/200 (ETDRS chart), CMT was 398 μ, and a subretinal subfoveal hemorrhage was seen. Tissue plasminogen activator (tPA) at a dose of 25 µg/0.1 mL was injected intravitreally before intravitreal C3F8 injection, and prone positioning was indicated postoperatively. At 24 hours, the hemorrhage had been displaced inferiorly and VA improved to 20/100. Two weeks later, VA improved to 20/80, CMT decreased to 225 μ, and the hemorrhage decreased without foveal involvement.Conclusions. The technique seems safe and effective in treating visually significant subretinal subfoveal hemorrhage.
机译:目的。研究全氟丙烷(C3F8)气体和玻璃体内组织纤溶酶原激活剂(IVTPA)置换治疗中央浆液性脉络膜视网膜病变(CSCR)后视网膜下凹下出血的视觉和解剖结果。一只眼(一名患者)的介入性回顾性病例报告。结果指标包括视力(VA),中央黄斑厚度(CMT)和随访两周时的病变大小。荧光血管造影(FA)和光学相干断层扫描(OCT)用于测量解剖结果。一位有慢性CSCR病史的35岁男性在出诊前两天在右眼接受了聚焦激光光凝治疗。初次检查时,VA为20/200(ETDRS图表),CMT为398μ,并观察到视网膜下凹下出血。在玻璃体内注射C3F8之前,玻璃体内注射剂量为25μg/0.1μmL的组织纤维蛋白溶酶原激活剂(tPA),并在手术后进行俯卧。在24小时时,出血已被完全清除,VA改善至20/100。两周后,VA增至20/80,CMT降至225μ,出血减少而无中央凹受累。该技术似乎在治疗视觉上明显的视网膜下凹下出血方面是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号